Biological Products, Except Diagnostic Substances (Biotech) - Latest Activist Disclosures

This table shows recent activist investor (Schedule 13D) filings made in this industry. Any investor or hedge fund that makes an investment with the intention of influencing management is considered an activist investor and must file a 13D.

Date Form Target Company Investor Shares Ownership
(Percent)		 Ownership Change
(Percent)
2024-04-26 13D/A CA:APS / Aptose Biosciences Inc. Hanmi Pharmaceutical Co., Ltd. 2,989,415 19.02
2024-04-25 13D/A SCLX / Scilex Holding Company SCLX Stock Acquisition JV LLC 89,616,299 33.30 0.00
2024-04-23 13D/A TCRX / TScan Therapeutics, Inc. Baker Bros. Advisors Lp 2,828,938 6.10 1.25
2024-04-22 13D/A TNYA / Tenaya Therapeutics, Inc. Beehouse, LLC 2,965,068 15.92 -13.31
2024-04-17 13D/A OTLK / Outlook Therapeutics, Inc. Syntone Ventures LLC 2,776,867 11.40 -85.99
2024-04-17 13D/A SRZN / Surrozen, Inc. Column Group Iii Gp, Lp 1,265,273 34.60 -0.87
2024-04-16 13D/A BCAB / BioAtla, Inc. Soleus Private Equity Fund I, L.P. 3,901,314 8.10 -7.56
2024-04-15 13D/A NVAX / Novavax, Inc. Shah Capital Management 9,383,335 6.70 106.19
2024-04-15 13D NVAX / Novavax, Inc. Shah Capital Management 9,383,335 6.70 106.19
2024-04-12 13D/A PASG / Passage Bio, Inc. Orbimed Advisors Llc 8,034,000 13.00 0.00
2024-04-09 13D/A ZIVO / ZIVO Bioscience, Inc. Strome Mezzanine Fund, Lp 256,150 9.10 -53.33
2024-04-08 13D/A IPSC / Century Therapeutics, Inc. Casdin Capital, LLC 3,206,380 4.95 -0.51
2024-04-08 13D/A SRZN / Surrozen, Inc. Column Group Iii Gp, Lp 1,276,384 34.90 -86.44
2024-04-08 13D/A SRZN / Surrozen, Inc. Column Group Iii Gp, Lp 1,276,384 34.90 -86.44
2024-04-05 13D/A TTNP / Titan Pharmaceuticals, Inc. Sire Group Ltd. 150,087 14.10 -95.00
2024-04-05 13D/A BCDA / BioCardia, Inc. Frost Gamma Investments Trust 1,286,454 4.80 -18.12
2024-04-02 13D/A ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) New Enterprise Associates 14, L.P. 102,478,672 6.70 0.00
2024-04-01 13D/A APGE / Apogee Therapeutics, Inc. Fairmount Funds Management LLC 4,762,558 9.99 -11.85
2024-04-01 13D KYMR / Kymera Therapeutics, Inc. Baker Bros. Advisors Lp 5,997,706 9.80 0.03
2024-03-25 13D/A ACLX / Arcellx, Inc. Sr One Capital Management, Llc 2,346,630 4.44 -25.42
2024-03-25 13D/A FATE / Fate Therapeutics, Inc. Redmile Group, LLC 17,619,095 14.90 17.07
2024-03-25 13D/A AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock) Kellnerova Renata 14,612,275 5.50
2024-03-22 13D PHGE / BiomX Inc. Flynn James E 6,110,098 11.06
2024-03-22 13D/A CMPX / Compass Therapeutics, Inc. Orbimed Advisors Llc 18,791,422 13.70 0.00
2024-03-20 13D/A OTLK / Outlook Therapeutics, Inc. GMS Ventures & Investments 9,266,645 37.00 -87.00
2024-03-19 13D/A PHGE / BiomX Inc. OrbiMed Israel BioFund GP Limited Partnership 12,577,821 19.90 173.32
2024-03-19 13D/A IOVA / Iovance Biotherapeutics, Inc. Quogue Capital LLC 30,000,000 11.60 20.00
2024-03-08 13D/A PHGE / BiomX Inc. OrbiMed Israel BioFund GP Limited Partnership 4,601,808 9.90 1.06
2024-03-08 13D/A HUMA / Humacyte, Inc. Niklason Laura E 10,153,195 8.40 1.02
2024-03-07 13D/A IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock) General Atlantic Llc 1,747,849 3.50 -32.95
2024-03-05 13D/A SCLX / Scilex Holding Company SCLX Stock Acquisition JV LLC 89,616,299 36.40 0.00
2024-03-04 13D/A ARMP / Armata Pharmaceuticals, Inc. Innoviva, Inc. 64,178,259 85.30 0.00
2024-02-27 13D/A BCDA / BioCardia, Inc. Frost Gamma Investments Trust 1,571,179 6.10 -17.13
2024-02-21 13D AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock) BioNTech SE 33,333,333 12.50
2024-02-20 13D/A CASI / CASI Pharmaceuticals, Inc. Sparkle Byte Ltd 1,019,852 7.60 -90.00
2024-02-14 13D INKT / MiNK Therapeutics, Inc. Armen Garo H 3,514,320 9.68
2024-02-14 13D/A MGTX / MeiraGTx Holdings plc Perceptive Advisors Llc 11,442,562 18.00 0.32
2024-02-14 13D/A TNYA / Tenaya Therapeutics, Inc. Column Group Iii, Lp 13,599,275 17.70 19.60
2024-02-14 13D/A VOR / Vor Biopharma Inc. 5AM Ventures VI, L.P. 6,361,723 9.40 -4.94
2024-02-09 13D/A JSPR / Jasper Therapeutics, Inc. Velan Capital Investment Management LP 1,471,903 9.80
2024-02-08 13D/A LCTX / Lineage Cell Therapeutics, Inc. Broadwood Partners, L.p. 41,983,883 22.20 19.18
2024-02-08 13D/A ALGS / Aligos Therapeutics, Inc. Versant Venture Capital VI, L.P. 1,457,937 1.90 0.00
2024-02-06 13D/A BCDA / BioCardia, Inc. Frost Gamma Investments Trust 1,896,025 8.80 -11.27
2024-02-06 13D/A PROK / ProKidney Corp. Tolerantia, LLC 88,639,961 37.60
2024-02-01 13D/A IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock) Baker Bros. Advisors Lp 2,452,871 4.99 -47.65
2024-01-31 13D/A SCLX / Scilex Holding Company SCLX Stock Acquisition JV LLC 89,616,299 38.20 0.00
2024-01-31 13D/A APGE / Apogee Therapeutics, Inc. Fairmount Funds Management LLC 5,403,053 9.99 38.32
2024-01-31 13D/A OTLK / Outlook Therapeutics, Inc. BioLexis Pte Ltd. 16,637,024 6.40 -14.03
2024-01-26 13D/A TNYA / Tenaya Therapeutics, Inc. Beehouse, LLC 3,420,381 18.36
2024-01-22 13D ZIVO / ZIVO Bioscience, Inc. Maggiore Christopher D. 355,158 12.80 -63.75